• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.69% Nasdaq Up 0.44%

    InVivo Therapeutics Holdings Corp. (NVIV)

    -NasdaqCM
    14.81 Down 0.22(1.46%) Jul 29, 4:00PM EDT
    |Pre-Market : 14.35 Down 0.46 (3.11%) 8:00AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:15.03
    Open:14.97
    Bid:14.26 x 100
    Ask:14.80 x 100
    1y Target Est:18.50
    Beta:2.28
    Next Earnings Date:N/A
    Day's Range:14.75 - 15.10
    52wk Range:1.88 - 19.68
    Volume:221,372
    Avg Vol (3m):411,530
    Market Cap:393.38M
    P/E (ttm):N/A
    EPS (ttm):-1.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NVIV

    Comparison

    Symbol% ChgMkt Cap
    NVIVDown 1.46%393.38M
    ACORDown 2.40%1.45B
    ALSE 0.00%398.26K
    STEM 0.00%44.14M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.63
    Quarterly EPS Est (Jun-15) :-0.20
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Invivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, focuses on developing and commercializing technologies for the treatment of spinal cord injury (SCI). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback